Survey Question | United States | Europe | Latin America | P-value | |||
---|---|---|---|---|---|---|---|
Yes (n (%)) | No (n (%)) | Yes (n (%)) | No (n (%)) | Yes (n (%)) | No (n (%)) | Statistical significance < 0.05 | |
“Does your institution provide proper protection for all health care workers to the level they are exposed?” | 759 (70.3%) | 320 (29.7%) | 58 (62.4%) | 35 (37.6%) | 104 (66.2%) | 53 (33.8%) | 0.168 |
“Have timely surgery/chemo/immunotherapy treatments for your patients been delayed since the COVID-19 pandemic started?” | 565 (56.8%) | 429 (432%) | 44 (50%) | 44 (50%) | 87 (56.1%) | 68 (43.9%) | 0.009 |
“Do you use telemedicine to reduce in-person encounters and health care providers’ exposure?” | 950 (88%) | 129 (12%) | 74 (81.3%) | 17 (18.7%) | 101 (63.9%) | 57 (36.1%) | < 0.001 |
“Have you been asked to reduce your specialized practice to help/contribute to other areas where urgent help is needed?” | 368 (34%) | 713 (66%) | 61 (65.6%) | 32 (34.4%) | 96 (61.5%) | 60 (38.5%) | < 0.001 |
“Have you had in service instruction/guidelines from leadership at your institution about policies to protect your patients, your team, your colleagues and yourself?” | 943 (86.7%) | 145 (13.3%) | 83 (89.2%) | 10 (10.8%) | 132 (84.1%) | 25 (15.9%) | 0.609 |
“Do you feel you have adequate support from your institution’s leadership to carry on with your duties?” | 800 (74.1%) | 279 (25.9%) | 56 (60.2%) | 37 (39.8%) | 96 (61.9%) | 59 (38.1%) | 0.001 |
“Do you discuss with all your patients the importance of strict adherence to COVID-19 community behavior as part of your office/clinic encounters?” | 978 (91.1%) | 95 (8.9%) | 87 (94.6%) | 5 (5.4%) | 152 (96.2%) | 6 (3.8%) | 0.035 |
“Do you have access to COVID-19 testing at your institution or local lab?” | 812 (75%) | 270 (25%) | 62 (66.7%) | 31 (33.3%) | 84 (53.5%) | 73 (46.5%) | < 0.001 |
“Has your institution used Tocilizumab or other anti-inflammatory agents for COVID-19 related myocarditis?” | 156 (16.9%) | 768 (83.1%) | 10 (11.6%) | 76 (88.4%) | 14 (9%) | 141 (91%) | < 0.001 |
Has your institution used empiric treatment with Remdesivir or other anti-viral treatments for the sickest patients? | 323 (33.8%) | 632 (66.2%) | 18 (20.7%) | 69 (79.3%) | 24 (15.4%) | 132 (84.6%) | < 0.001 |
“In your opinion, should there be a government mandated nationwide quarantine/lock-down to slow down the propagation/transmission of COVID-19?” | 910 (84.4%) | 168 (15.6%) | 84 (92.3%) | 7 (7.7%) | 142 (91.6%) | 13 (8.4%) | 0.152 |
“Should medical professional organizations take a more active role, and have more influence in official health care policy decisions during this major crisis?” | 1035 (95.5%) | 49 (4.5%) | 88 (95.7%) | 4 (4.3%) | 147 (93.6%) | 10 (6.4%) | 0.765 |